Despite anatomical proximity, prostatic adenocarcinoma with rectal invasion is extremely rare. We present a case of rectal invasion by prostatic adenocarcinoma that was initially diagnosed from a rectal polyp biopsied on colonoscopy in a 69-year-old Korean man. He presented with dull anal pain and voiding discomfort for several days. Computed tomography revealed either prostatic adenocarcinoma with rectal invasion or rectal adenocarcinoma with prostatic invasion. His tumor marker profile showed normal prostate specific antigen (PSA) level and significantly elevated carcinoembryonic antigen level. Colonoscopy was performed, and a specimen was obtained from a round, 1.5 cm, sessile polyp that was 1.5 cm above the anal verge. Microscopically, glandular tumor structures infiltrated into the rectal mucosa and submucosa. Immunohistochemically, the tumor cells showed alpha-methylacyl-CoA-racemase positivity, PSA positivity, and caudal-related homeobox 2 negativity. The final diagnosis of the rectal polyp was consistent with prostatic adenocarcinoma. Here, we present a rare case that could have been misdiagnosed as rectal adenocarcinoma.
Citations
Citations to this article as recorded by
Prostate cancer invading rectal serosa and anal sphincter treated with definitive radiation therapy: Case report and review of the literature Mi-Jo Lee Journal of Cancer Research and Therapeutics.2024; 20(3): 1081. CrossRef
Metastatic Adenocarcinoma of the Prostate Masquerading as a Splenic Flexure Colonic Polyp: A Diagnostic Conundrum Zakaria W Shkoukani, Alaa Chamsin, Mohamed I Abdulmajed Cureus.2024;[Epub] CrossRef
An Interesting Case of Prostate Cancer Presenting With Colonic Metastasis Shawn Keating, Ayesha Imtiaz, Kenneth Nahum, Ankita Prasad, Pramil Cheriyath Cureus.2023;[Epub] CrossRef
Metastase d’un adenocarcinome prostatique au sein d’un polype colique. À propos d’un cas et revue de la littérature Guillaume Abitbol, Clémence Barthomeuf, Olivier Varennes, Marine Clement, Sami Hakim, Denis Chatelain Annales de Pathologie.2023; 43(4): 342. CrossRef
Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT Shashank Shekhar Singh, Rani Kunti Randhir Singh, Narvesh Kumar, Harshvardhan Atrey World Journal of Nuclear Medicine.2022; 21(03): 248. CrossRef
Metastatic Prostate Cancer Presenting as a Rectal Polyp: A Rare Occurrence Ese Uwagbale, Ifeanyichukwu Onukogu, Vimal Bodiwala, Solomon Agbroko, Niket Sonpal Cureus.2021;[Epub] CrossRef
Local Staging of Prostate Cancer with Multiparametric MRI Nandan Keshav, Mark D. Ehrhart, Steven C. Eberhardt, Martha F. Terrazas Seminars in Roentgenology.2021; 56(4): 366. CrossRef
Background The pathologic distinction between high-grade prostate adenocarcinoma (PAC) involving the urinary bladder and high-grade urothelial carcinoma (UC) infiltrating the prostate can be difficult. However, making this distinction is clinically important because of the different treatment modalities for these two entities.
Methods A total of 249 patient cases (PAC, 111 cases; UC, 138 cases) collected between June 1995 and July 2009 at Seoul St. Mary’s Hospital were studied. An immunohistochemical evaluation of prostatic markers (prostate-specific antigen [PSA], prostate-specific membrane antigen [PSMA], prostate acid phosphatase [PAP], P501s, NKX3.1, and α-methylacyl coenzyme A racemase [AMACR]) and urothelial markers (CK34βE12, p63, thrombomodulin, S100P, and GATA binding protein 3 [GATA3]) was performed using tissue microarrays from each tumor.
Results The sensitivities of prostatic markers in PAC were 100% for PSA, 83.8% for PSMA, 91.9% for PAP, 93.7% for P501s, 88.3% for NKX 3.1, and 66.7% for AMACR. However, the urothelial markers CK34βE12, p63, thrombomodulin, S100P, and GATA3 were also positive in 1.8%, 0%, 0%, 3.6%, and 0% of PAC, respectively. The sensitivities of urothelial markers in UC were 75.4% for CK34βE12, 73.9% for p63, 45.7% for thrombomodulin, 22.5% for S100P, and 84.8% for GATA3. Conversely, the prostatic markers PSA, PSMA, PAP, P501s, NKX3.1, and AMACR were also positive in 9.4%, 0.7%, 18.8%, 0.7%, 0%, and 8.7% of UCs, respectively.
Conclusions Prostatic and urothelial markers, including PSA, NKX3.1, p63, thrombomodulin, and GATA3 are very useful for differentiating PAC from UC. The optimal combination of prostatic and urothelial markers could improve the ability to differentiate PAC from UC pathologically.
Citations
Citations to this article as recorded by
Unusual Perineal Metastasis in a Case of Prostate Cancer on 68Ga-PSMA-11 PET/CT Ritanshu Solanki, Bhagwant Rai Mittal, Rajender Kumar, Aravindh Sekar, Narender Kumar Clinical Nuclear Medicine.2024; 49(2): e73. CrossRef
NKX3.1 Expression in Non-Prostatic Tumors and Characterizing its Expression in Esophageal/Gastroesophageal Adenocarcinoma Ansa Mehreen, Kiran G. Manjee, Divyangi Paralkar, Gladell P. Paner, Thanh Lan Advances in Anatomic Pathology.2024; 31(3): 202. CrossRef
Clinical Management of Intraductal Carcinoma of the Prostate Gabriel Wasinger, Olivier Cussenot, Eva Compérat Cancers.2024; 16(9): 1650. CrossRef
Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy Daniel H. Russell, Jonathan I. Epstein, Oleksandr N. Kryvenko, Matthew Schlumbrecht, Merce Jorda, Andre Pinto Archives of Pathology & Laboratory Medicine.2024; 148(6): 705. CrossRef
Assessing the diagnostic impact of P63, PSA and BCL-2 proteins in premalignant and malignant prostate tissues Aderonke C. Ogunlayi, Victor O. Ekundina, Adedapo O. Kehinde, Linus A. Enye, Adegoke O. Aremu International Journal of Scientific Reports.2024; 10(6): 188. CrossRef
Concurrent occurrence of adenocarcinoma and urothelial carcinoma of the prostate gland: A case report Jhe Yuan Hsu, Yi Sheng Lin, Li Hua Huang, Tang Yi Tsao, Chao Yu Hsu, Yen Chuan Ou, Min Che Tung World Journal of Clinical Cases.2024; 12(26): 5952. CrossRef
Metastatic prostate cancer presenting as a posterior mediastinal mass: A rare presentation Muhammad Haider, Arun Umesh Mahtani, Bachar Botrus, Foma Munoh Kenne, Madiha Fatima Master Clinical Case Reports.2023;[Epub] CrossRef
Diagnostic and Prognostic Roles of GATA3 Immunohistochemistry in Urothelial Carcinoma Daeseon Yoo, Kyueng-Whan Min, Jung-Soo Pyo, Nae Yu Kim Medicina.2023; 59(8): 1452. CrossRef
Primary high-grade urothelial carcinoma of prostate with prostatic hyperplasia: a rare case report and review of the literature Liang Liu, Fu-zhen Sun, Pan-ying Zhang, Yu Xiao, Xiao Yue, Dong-Ming Wang, Qiang Wang The Aging Male.2023;[Epub] CrossRef
Expression of Gata Binding Protein 3 as a Prognostic Factor in Urogenital Lesions and Its Association With Morphology T Govardhan, Debahuti Mohapatra, Sujata Naik, Prateek Das, Pranita Mohanty, Ankita Pal Cureus.2023;[Epub] CrossRef
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component Simone de Brot, Jennifer Lothion‐Roy, Llorenç Grau‐Roma, Emily White, Franco Guscetti, Mark A. Rubin, Nigel P. Mongan Veterinary and Comparative Oncology.2022; 20(1): 38. CrossRef
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications Arsalan Tariq, Amy E. McCart Reed, Andrew Morton, Sima Porten, Ian Vela, Elizabeth D. Williams, John W. Yaxley, Peter C. Black, Matthew J. Roberts European Urology Focus.2022; 8(5): 1256. CrossRef
Immunohistochemical Reactivity of Prostate-Specific Membrane Antigen in Salivary Gland Tumors Haruto Nishida, Yoshihiko Kondo, Takahiro Kusaba, Hiroko Kadowaki, Tsutomu Daa Head and Neck Pathology.2022; 16(2): 427. CrossRef
Weak NKX3.1 expression in a urothelial carcinoma: A diagnostic pitfall Maryam Abdo, Robert Hoyt, Ashley Highfill, Daniel Mettman Human Pathology Reports.2022; 27: 300599. CrossRef
Gene of the month: NKX3.1 Jon Griffin, Yuqing Chen, James W F Catto, Sherif El-Khamisy Journal of Clinical Pathology.2022; 75(6): 361. CrossRef
Diagnostic Value of GATA3 and Uroplakin 3 in Differentiating Urothelial Carcinoma from Prostatic and Colorectal Carcinoma Maha Salama, Dina A. Khairy Open Access Macedonian Journal of Medical Sciences.2022; 10(A): 514. CrossRef
Diagnostic challenges for the distinction of high-grade prostatic adenocarcinoma and high-grade urothelial carcinoma of simultaneous occurrences - A literature review Shreyas Bhushan Jayade, Manana Jikurashvili GEORGIAN SCIENTISTS.2022;[Epub] CrossRef
Cytomorphology, immunoprofile, and clinicopathologic correlation of metastatic prostatic carcinoma Xiaoqi Lin, Qiuying Shi, Ximing J. Yang Human Pathology.2022; 130: 36. CrossRef
Cutaneous Metastasis of Prostate Adenocarcinoma: A Rare Presentation of a Common Disease Alexander Dills, Okechukwu Obi, Kevin Bustos, Jesse Jiang, Shweta Gupta Journal of Investigative Medicine High Impact Case Reports.2021;[Epub] CrossRef
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma Ewe Seng Ch’ng Scientific Reports.2021;[Epub] CrossRef
Immunohistochemical analysis of thrombomodulin expression in myocardial tissue from autopsy cases of ischemic heart disease Takeshi Kondo, Motonori Takahashi, Gentaro Yamasaki, Marie Sugimoto, Azumi Kuse, Mai Morichika, Kanako Nakagawa, Makoto Sakurada, Migiwa Asano, Yasuhiro Ueno Legal Medicine.2021; 51: 101897. CrossRef
Application and Pitfalls of Immunohistochemistry in Diagnosis of Challenging Genitourinary Cases Jenny Ross, Guangyuan Li, Ximing J. Yang Archives of Pathology & Laboratory Medicine.2020; 144(3): 290. CrossRef
New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers Karin Ried, Tasnuva Tamanna, Sonja Matthews, Peter Eng, Avni Sali Frontiers in Oncology.2020;[Epub] CrossRef
An Unlikely Culprit: Gastric Metastasis from Primary Prostatic Adenocarcinoma Eric Omar Then, Spoorthi Nutakki, Andrew Ofosu, Saad Saleem, Vijay Gayam, Tagore Sunkara, Vinaya Gaduputi Journal of Gastrointestinal Cancer.2020; 51(3): 1081. CrossRef
MRI of prostatic urethral mucinous urothelial carcinoma: Expanding the differential diagnosis for T2 hyperintense prostatic masses Neel Patel, Bryan R. Foster, Elena K. Korngold, Kyle Jensen, Kevin R. Turner, Fergus V. Coakley Clinical Imaging.2020; 68: 68. CrossRef
Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review Francesca Sanguedolce, Davide Russo, Vito Mancini, Oscar Selvaggio, Beppe Calò, Giuseppe Carrieri, Luigi Cormio International Journal of Surgical Pathology.2019; 27(2): 120. CrossRef
A Case of Metastatic Prostate Cancer to the Urethra That Resolved After Androgen Deprivation Therapy Darren J. Bryk, Kenneth W. Angermeier, Eric A. Klein Urology.2019; 129: e4. CrossRef
The Homeodomain Transcription Factor NKX3.1 Modulates Bladder Outlet Obstruction Induced Fibrosis in Mice Mehul S. Patel, Diana K. Bowen, Nicholas M. Tassone, Andrew D. Gould, Kirsten S. Kochan, Paula R. Firmiss, Natalie A. Kukulka, Megan Y. Devine, Belinda Li, Edward M. Gong, Robert W. Dettman Frontiers in Pediatrics.2019;[Epub] CrossRef
Cancer of unknown primary: Ancillary testing of cytologic and small biopsy specimens in the era of targeted therapy Morgan L. Cowan, Christopher J. VandenBussche Cancer Cytopathology.2018; 126(S8): 724. CrossRef
Glandular Tumors of the Urachus and Urinary Bladder: A Practical Overview of a Broad Differential Diagnosis Alexander S. Taylor, Rohit Mehra, Aaron M. Udager Archives of Pathology & Laboratory Medicine.2018; 142(10): 1164. CrossRef
S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers Moushumi Suryavanshi, Julian Sanz-Ortega, Deepika Sirohi, Mukul K. Divatia, Chisato Ohe, Claudia Zampini, Daniel Luthringer, Steven C. Smith, Mahul B. Amin Advances in Anatomic Pathology.2017; 24(3): 151. CrossRef